TheJAK2V617F Mutation is Absent in Patients with Erythrocytosis Due to High Oxygen Affinity Hemoglobin Variants
- 1 January 2006
- journal article
- Published by Informa UK Limited in Hemoglobin
- Vol. 30 (4), 487-489
- https://doi.org/10.1080/03630260600868147
Abstract
High oxygen affinity hemoglobin (Hb) variants are an important and well characterized cause of secondary erythrocytosis. We tested 22 patients with high oxygen affinity beta chain variants for the presence of the JAK2 V617F mutation that has been reported in chronic myeloproliferative disorders, particularly polycythemia vera. All specimens showed the absence of this mutation. This observation contributes to the overall clinical specificity of the JAK2 V617F mutation.Keywords
This publication has 6 references indexed in Scilit:
- The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemiaBlood, 2005
- Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disordersLeukemia, 2005
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersThe Lancet, 2005
- Three New Hemoglobin Variants with Abnormal Oxygen Affinity: Hb Saratoga Springs [α40(C5)Lys→Asn (α1)], Hb Santa Clara [β97(FG4)His→Asn], and Hb Sparta [β103(G5)Phe→Val]Hemoglobin, 2003